Jones Financial Companies’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411K Buy
13,614
+9,337
+218% +$263K ﹤0.01% 2296
2026
Q1
$124K Buy
4,277
+3,762
+730% +$128K ﹤0.01% 2583
2025
Q4
$20.4K Buy
515
+135
+36% +$4.95K ﹤0.01% 2925
2025
Q3
$13.4K Hold
380
– – ﹤0.01% 2976
2025
Q2
$12.3K Hold
380
– – ﹤0.01% 2798
2025
Q1
$12.1K Buy
+380
New +$14.1K ﹤0.01% 2631

Other funds holding ATRC

Jones Financial Companies's ATRC Position: Q2 2026 in Review

Jones Financial Companies increased its AtriCure (ATRC) stake by 218% in Q2 2026, buying an estimated $263K and bringing the position to 13,614 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Jones Financial Companies first reported a position in ATRC in Q1 2025 and has held it in 6 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Jones Financial Companies held 13,614 shares of AtriCure worth $411K as of Q2 2026.
  • Jones Financial Companies bought 9,337 AtriCure shares in Q2 2026, an estimated $263K.
  • AtriCure made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2296 holding.
  • Jones Financial Companies first reported a position in AtriCure in Q1 2025 and has held it in 6 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.